Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    23008465 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting High-dose Erythropoietin for Asphyxia and Encephalopathy
Conditions: Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Normal saline placebo;   Drug: erythropoietin
2 Active, not recruiting Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Conditions: Hypoxic-ischemic Encephalopathy;   Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Erythropoietin;   Drug: Normal saline
3 Completed Neonatal Erythropoietin in Asphyxiated Term Newborns
Condition: Hypoxic-ischemic Encephalopathy
Intervention: Drug: erythropoietin

Indicates status has not been verified in more than two years